These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1879957)

  • 1. Liposomes and nanoparticles as vehicles for antibiotics.
    Kreuter J
    Infection; 1991; 19 Suppl 4():S224-8. PubMed ID: 1879957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ectericide as a dispersion medium for the preparation of prospective clinical liposomal drug forms].
    Dikiĭ IL; Strel'nikov LS; Chueshov VI; Iakovenko VD; Bazavluk AD
    Vestn Akad Med Nauk SSSR; 1990; (6):40-4. PubMed ID: 2220037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal amikacin: improved treatment of Mycobacterium avium complex infection in the beige mouse model.
    Petersen EA; Grayson JB; Hersh EM; Dorr RT; Chiang SM; Oka M; Proffitt RT
    J Antimicrob Chemother; 1996 Nov; 38(5):819-28. PubMed ID: 8961051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications.
    Pinto-Alphandary H; Andremont A; Couvreur P
    Int J Antimicrob Agents; 2000 Jan; 13(3):155-68. PubMed ID: 10724019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposome-encapsulated antibiotics.
    Salem II; Flasher DL; Düzgüneş N
    Methods Enzymol; 2005; 391():261-91. PubMed ID: 15721386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomes and lipid carriers in the treatment of microbial infections.
    Bakker-Woudenberg IA; Lokerse AF
    Scand J Infect Dis Suppl; 1990; 74():34-41. PubMed ID: 2097717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Liposomes: promising perspectives].
    Bricaire F
    Presse Med; 1998 Dec; 27 Suppl 5():7-8. PubMed ID: 9879327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes in the treatment of infections.
    Bakker-Woudenberg IA; Storm G; Woodle MC
    J Drug Target; 1994; 2(5):363-71. PubMed ID: 7704480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug targeting in Leishmania donovani infections using tuftsin-bearing liposomes as drug vehicles.
    Guru PY; Agrawal AK; Singha UK; Singhal A; Gupta CM
    FEBS Lett; 1989 Mar; 245(1-2):204-8. PubMed ID: 2538359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomes and nanoparticles in the treatment of intracellular bacterial infections.
    Couvreur P; Fattal E; Andremont A
    Pharm Res; 1991 Sep; 8(9):1079-86. PubMed ID: 1788152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
    Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
    Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
    Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides.
    Bermudez LE; Yau-Young AO; Lin JP; Cogger J; Young LS
    J Infect Dis; 1990 Jun; 161(6):1262-8. PubMed ID: 2345306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid-modified mesoporous silica nanoparticles with pH-responsiveness loaded with Amp for an enhanced effect against anti-drug-resistant bacteria by overcoming efflux pump systems.
    Chen X; Liu Y; Lin A; Huang N; Long L; Gang Y; Liu J
    Biomater Sci; 2018 Jun; 6(7):1923-1935. PubMed ID: 29850668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomes as carriers of antimicrobial agents or immunomodulatory agents in the treatment of infections.
    Bakker-Woudenberg IA; Lokerse AF; ten Kate MT; Melissen PM; van Vianen W; van Etten EW
    Eur J Clin Microbiol Infect Dis; 1993; 12 Suppl 1():S61-7. PubMed ID: 8477767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of liposome-entrapped ampicillin in vitro and in vivo in relation to the lipid composition.
    Bakker-Woudenberg IA; Lokerse AF; Roerdink FH
    J Pharmacol Exp Ther; 1989 Oct; 251(1):321-7. PubMed ID: 2507773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of drug-loaded polymeric nanoparticles and evaluation of the antioxidant activity against lipid peroxidation.
    Pohlmann AR; Schaffazick SR; Creczynski-Pasa TB; Guterres SS
    Methods Mol Biol; 2010; 610():109-21. PubMed ID: 20013175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ultrasonication on the stability of oligonucleotides adsorbed on nanoparticles and liposomes.
    Zobel HP; Werner D; Gilbert M; Noe CR; Stieneker F; Kreuter J; Zimmer A
    J Microencapsul; 1999; 16(4):501-9. PubMed ID: 10420334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparation and anti-breast cancer activity of (-)-antofine carried with liposomes].
    Wu DM; Chen Y; Wu L
    Zhong Yao Cai; 2013 Sep; 36(9):1511-4. PubMed ID: 24620699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of a cedrol-loaded nanostructured lipid carrier system for in vitro and in vivo susceptibilities of wild and drug resistant Leishmania donovani amastigotes.
    Kar N; Chakraborty S; De AK; Ghosh S; Bera T
    Eur J Pharm Sci; 2017 Jun; 104():196-211. PubMed ID: 28400285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.